Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1308345
PUBLISHER: IMARC | PRODUCT CODE: 1308345
Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Market Overview:
The global lung marker market size reached US$ 393.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 731.0 Million by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028.
Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.
The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global lung marker market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cancer type, marker type and end user.
Breakup by Cancer Type:
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)
Breakup by Marker Type:
EGFR
EML4-ALK
KRAS
BRAF
Others
Breakup by End User:
Hospitals
Diagnostic Labs
Others
Breakup by Region:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Iran
Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.
Key Questions Answered in This Report:
- How has the global lung marker market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global lung marker market?
- What are the key regional markets?
- What is the breakup of the market based on the cancer type?
- What is the breakup of the market based on the marker type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global lung marker market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A2063
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Lung Marker Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact Of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Cancer Type
- 6.1 Non-Small Cell Lung Cancer (NSCLC)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Small Cell Lung Cancer (SCLC)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Marker Type
- 7.1 EGFR
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 EML4-ALK
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 KRAS
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 BRAF
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diagnostic Labs
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Europe
- 9.2.1 Germany
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 France
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 United Kingdom
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 Italy
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Spain
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Russia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 Germany
- 9.3 Asia Pacific
- 9.3.1 China
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 Japan
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 India
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 South Korea
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Australia
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Indonesia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 China
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Argentina
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.4 Colombia
- 9.4.4.1 Market Trends
- 9.4.4.2 Market Forecast
- 9.4.5 Chile
- 9.4.5.1 Market Trends
- 9.4.5.2 Market Forecast
- 9.4.6 Peru
- 9.4.6.1 Market Trends
- 9.4.6.2 Market Forecast
- 9.4.7 Others
- 9.4.7.1 Market Trends
- 9.4.7.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Turkey
- 9.5.1.1 Market Trends
- 9.5.1.2 Market Forecast
- 9.5.2 Iran
- 9.5.2.1 Market Trends
- 9.5.2.2 Market Forecast
- 9.5.3 Others
- 9.5.3.1 Market Trends
- 9.5.3.2 Market Forecast
- 9.5.1 Turkey
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Thermo Fisher Scientific Inc
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Agilent Technologies, Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Beckman Coulter, Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Fujirebio Europe N.V., Hologic, Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 F. Hoffmann-La Roche Ltd
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Siemens Healthineers
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 BioSpace, Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
Product Code: SR112023A2063
List of Figures
- Figure 1: Global: Lung Marker Market: Major Drivers and Challenges
- Figure 2: Global: Lung Marker Market: Sales Value (in Million US$), 2017-2022
- Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2022
- Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2022
- Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2022
- Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2022
- Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: North America: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: United States: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Canada: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: China: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Japan: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: India: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: South Korea: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Australia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Europe: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Germany: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: France: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Italy: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Spain: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Russia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Turkey: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Iran: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Latin America: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Brazil: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Mexico: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 80: Argentina: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 82: Colombia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 84: Chile: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 86: Peru: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 88: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
- Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 90: Global: Lung Marker Industry: SWOT Analysis
- Figure 91: Global: Lung Marker Industry: Value Chain Analysis
- Figure 92: Global: Lung Marker Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Lung Marker Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
- Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million US$), 2023-2028
- Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million US$), 2023-2028
- Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Lung Marker Market: Competitive Structure
- Table 7: Global: Lung Marker Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.